• Tech
  • Business
  • London
  • Legal & Compliance
  • Pharma & Biotech
  • International

Mobile Logo

Tim Ashour

Timothy has been a journalist for over 15 years. He has covered business and consumer technology news, and financial analysis.

September 21, 2026
Latest News

Airtel Africa (AAF) Drops 10% In A Day But Long-Term Case Remains Compelling

Airtel Africa (LSE: AAF) has been among the standout performers in the FTSE 100 since joining the blue-chip index in January 2022, surging 124% over that period. Investors who backed the African

Latest News

Accenture (ACN), Abivax (ABVX), And Three Other Stocks Set To Shape Monday’s Trading Session

Accenture (ACN) is among a handful of stocks drawing significant investor attention as markets prepare to open for the new trading week. Abivax (ABVX), the French biopharmaceutical company, is also on the watchlist of traders and analysts monitoring early market

September 21, 2026

Sun Pharma Launches Fashion-Inspired Alopecia Areata Awareness Campaign Featuring Designer Christian Siriano

Latest News/Pharma & Biotech

Sun Pharmaceutical Industries Limited has unveiled a new educational campaign called Regrowth Restyled, aimed at supporting adults living with severe alopecia areata. The campaign

Patent Holders Cannot Escape Marking Statute Through Covenants Not To Sue, Courts Suggest

Latest News/Legal & Compliance

Patent holders seeking to sidestep the marking statute through clever settlement structuring are unlikely to find safe harbour in covenants not to sue. The

corporate lawyer attorney US legal bankruptcy contract case
Latest News/Pharma & Biotech

Eli Lilly (LLY) Wins FDA Approval For Inluriyo And Verzenio Combination In ESR1-Mutated Breast Cancer

Eli Lilly (LLY) has secured a second FDA approval for its oral SERD Inluriyo in under a year, this time in combination with its CDK4/6 inhibitor Verzenio. The regimen is now approved

More
by Tim Ashour
September 19, 2026
Latest News/Legal & Compliance

Second Circuit Clarifies Religious Accommodation Standard, No Proof Of Anti-Religious Animus Required

The U.S. Court of Appeals for the Second Circuit has amended a recent ruling, bringing significant clarity to Title VII religious accommodation cases across the circuit. The amended decision, issued on September

More
by Tim Ashour
September 19, 2026
Latest News

Three Key Factors To Weigh Before Loading Your ISA With High-Yield Dividend Shares

Filling a Stocks and Shares ISA with high-yield dividend shares is a popular strategy for investors seeking to build long-term passive income streams. The approach can be highly rewarding, but it carries

More
by Tim Ashour
September 19, 2026
Latest News

Rapid Cell Banking Push Tests Charles River Laboratories’ (CRL) Growth Story

Charles River Laboratories International (CRL) has long been a dominant force in preclinical drug development services, supplying pharmaceutical and biotech clients worldwide. The company operates across a broad range of services, including

More
by Tim Ashour
September 19, 2026
Latest News/Pharma & Biotech

Europe’s CHMP Backs Dozen New Medicines Including Novo Nordisk (NVO) And AstraZeneca (AZN) Offerings

The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended 12 new medicines for approval at its September 2026 meeting. The CHMP also backed extensions of indication for 11 existing

More
by Tim Ashour
September 18, 2026
Business/Latest News/Legal & Compliance/Tech/UK

Google (GOOGL) Avoids AdX Breakup As Court Orders Behavioral Fixes In Ad Tech Monopoly Case

A federal court has declined to force Google to sell its ad exchange or open-source its auction logic in a landmark US antitrust ruling. Judge Leonie Brinkema of the Eastern District of

More
by Tim Ashour
September 18, 2026September 19, 2026
Latest News/Legal & Compliance

FCC Boss Brendan Carr Dismisses Jimmy Kimmel Broadcast Censorship Row As A Hoax

Brendan Carr, the Federal Communications Commission chairman, has dismissed claims of censorship as a hoax following a row involving comedian Jimmy Kimmel and ABC. Jimmy Kimmel revealed last week that his late-night

More
by Tim Ashour
September 18, 2026
dwp raises pip benefits to include £737 more a year
Latest News

WisdomTree (WT) Valuation Raises Concern After Remarkable 303% Five-Year Surge

WisdomTree Investments (WT) has delivered an extraordinary return of 303% over the past five years, cementing its place among notable financial sector performers. Despite the impressive multi-year run, analysts are now questioning

More
by Tim Ashour
September 18, 2026
Latest News

FTSE 100 Drops 99 Points As FTSE 250 Also Falls Into Negative Territory

The FTSE 100 index recorded a significant decline of 99 points during the latest trading session, adding to investor concerns about ongoing market volatility. The broader mid-cap index, the FTSE 250, also

More
by Tim Ashour
September 18, 2026
Latest News/Pharma & Biotech

Bavarian Nordic (BAVA) Names Sanofi And AstraZeneca Veteran Tarja Stenvall As New CEO

Bavarian Nordic A/S (OMX: BAVA) has appointed Tarja Stenvall as President and Chief Executive Officer, effective October 15, 2026, succeeding longtime leader Paul Chaplin. Stenvall brings more than 20 years of global

More
by Tim Ashour
September 18, 2026
Previous 1 2 3 4 … 236 Next

UK Economy Set To Grow 1.3% In 2026 Despite Energy Bill Pressures And Higher Borrowing Costs

Sydney Sweeney’s Novig Ad Controversy Reveals A Powerful Shift In Women’s Sport

London Insider © 2026 - All Rights Reserved. London Insider is a leading UK-headquartered news publication, covering financial news, tech and more.

  • Home
  • About Us
  • Tourist Guide
  • Advertise
  • Contact Us
  • Tech
  • Business
  • London
  • Legal & Compliance
  • Pharma & Biotech
  • International